Financials

  • Market Capitalization 1.94 B
  • Employee 260
  • Founded 1997
  • CEO N/A
  • Website www.xencor.com
  • Headquarter Delaware, United States
  • FIGI BBG0026ZG4W0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.35
Relación precio/flujo de caja
9.05

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2009
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
7.68 USD-8.24%-10.59%+16.36%+221.34%1.99 B USD
2011
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
33.32 USD-2.80%+0.21%+13.03%-23.21%1.99 B USD
2045
IMCR
Immunocore Holdings plc - American Depositary Shares
36.62 USD-0.35%-0.38%+10.10%+9.38%1.89 B USD
2048
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.77 USD-3.19%-4.15%+2.85%+98.97%1.88 B USD

Noticias